Filing Details
- Accession Number:
- 0001144204-19-027313
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-20 16:32:16
- Reporting Period:
- 2019-05-17
- Accepted Time:
- 2019-05-20 16:32:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1023024 | Ani Pharmaceuticals Inc | ANIP | Pharmaceutical Preparations (2834) | 582301143 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1579587 | G. James Marken | C/O Ani Pharmaceuticals, Inc. 210 Main Street West Baudette MN 56623 | Svp Ops & Prod Dev | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-05-17 | 8,907 | $70.67 | 61,230 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The shares were sold in multiple trades at prices ranging from $70.50 to $71.00. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.